Elad Gil β 2024 Investments
3 investments dated 2024 Β· listed companies and verified rows first Β· show all
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Executive Officer, Director)Eric Morgen(Director)Dov Goldstein(Executive Officer)
BoardPatrick Enright(Director)
Co-investorsAndreessen HorowitzFelicis VenturesIA Seed VenturesLongitude CapitalOrbiMedSofinnova Ventures+2 more
Decagon provides AI agents that enable businesses to deliver personalized customer experiences at scale.
AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US
Jesse Zhang(Executive Officer, Director)inIvan Zhou(Director)in
BoardAaref Hilaly(Director)inAshwin Sreenivas(Director)in
Co-investorsA*AccelACME CapitalAndreessen HorowitzAtacama VenturesAudacious+8 more
HeyGen is an AI video generation and dubbing platform that allows users to create and localize videos by writing scripts and selecting AI-generated voices, eliminating the need for cameras, actors, and traditional production resources.
AI & Machine LearningMarketing TechMedia & EntertainmentSaaSLos Angeles, US
Joshua Xu(Co-founder and Chief Executive Officer)Wayne Liang(Co-founder and Chief Innovation Officer)Joshua X.(Founder)inJoshua X
BoardSarah Guo(Board member; founder of Conviction)
Co-investorsConvictionBenchmarkThrive CapitalBONDDylan FieldIDG Capital+2 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.